Mostafa Ghanei, the secretary of the Biotechnology Development Headquarters in the Vice President of Science and Technology, said on Wednesday that Iran’s strategy is to set up domestically developed biological technologies in neighboring states in accordance with economic considerations.
Russia, Turkiye, and Oman are the main destinations of the program in order to pave the ground for producing biotech products in joint ventures, Ghanei said, noting that the plan will help supply the Iranian goods to other countries and provide these states with the capabilities of the Iranians.
The Biotechnology Development Headquarters in the Vice President of Science and Technology will make all-out efforts to pave the way for the development of biological technology in line with the progress taking place in the world, he argued.
As to the impact of the cruel unilateral sanctions on Iran, he said that the Iranian youths and experts are facing the serious challenge of embargo when it comes to pursuing progress as well as presence in international markets, so the sanctions are a big hurdle in the way of showcasing the capabilities of the Iranian scientists and producers to the world.
Many analysts are of the opinion that the sanctions get in the way of the Iranians in introducing and selling their state-of-the-art products, including biotech productions.
4208**9417
Your Comment